Epidemiological aspects of mycosis in the critical patient;Aspectos epidemiológicos de las micosis en el paciente crítico

Revista Espanola de Quimioterapia

Volumn 21, Issue SPEC. ISS. 1, 2008, Pages 7-8

  García, Javier Pemán ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Aspergillosis; Candidemia; Fungemia; UCI

Indexed keywords

GLUCOCORTICOID;

ARTICLE; ASPERGILLOSIS; ASPERGILLUS; BLOOD CULTURE; BRONCHUS DISEASE; CANDIDA; CANDIDEMIA; CANDIDIASIS; CRITICALLY ILL PATIENT; FUNGEMIA; FUNGUS ISOLATION; HOSPITAL INFECTION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; LUNG MYCOSIS; MORTALITY; MYCOSIS; NONHUMAN; PREVALENCE; PROGNOSIS; RISK FACTOR;

CRITICAL ILLNESS; HUMANS; MYCOSES;

EID: 54949131683     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. León C, Ruiz-Santana S, Saavedra P. A bedside scoring system ( Candida score) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 2006;34:730-7.
2. Zaragoza R, Pemán J. Diagnostic and therapeutic approach to fungal infections in critical care settings: different options but the same strategy. J Invasive Fungal Infect 2007 2007;1:50-8.
3. Tortorano AM, Pemán J, Bernhardt H. Epidemiology of candidaemia in Europe: results of 28 month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 2004;23:317-22.
4. Meersseman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans WE, Van Wijngaerden E. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med 2004; 170:621-5.